Last updated: March 20, 2025
Sponsor: Nanchong Central Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hernia
Treatment
To remove the uterine uterine ligament
Clinical Study ID
NCT06885788
2025006
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
►Age : Female patients over 18 years of age without a childbearing requirement
Diagnosis and basis : Female patients diagnosed with Unilateral inguinalhernia.
agreed to participate in this study and signed the informed consent form.
Exclusion
Exclusion Criteria:
►Combined with severe heart, liver, kidney and other diseases.
pregnant or lactating women.
those with surgical contraindications.
Study Design
Total Participants: 466
Treatment Group(s): 1
Primary Treatment: To remove the uterine uterine ligament
Phase:
Study Start date:
September 20, 2024
Estimated Completion Date:
March 01, 2027
Connect with a study center
Nanchong Central Hospital
Nanchong, Sichuan 637000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.